Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Copyright Confusion Has 'Chilling' Effects in Online Creative Publishing

  • Human mind: Making sense through order

  • Amputee makes history controlling two modular prosthetic limbs

  • Scientists map out how childhood brain tumors relapse

  • Scheduling sleep: Three nighttime habits to improve rest

  • Ability to balance on one leg may reflect brain health, stroke risk

  • Being humble: Research shows E.B. White was right in Charlotte's Web

  • Outreach program gets cessation help to smokers of low socioeconomic status

  • Yoga has potential to reduce risk factors of cardiovascular disease

  • How does prostate cancer form? Parkinson's Link?

  •